Orange Book product · Generic (ANDA)
ESTROPIPATE
ESTROPIPATE
At a glance
Nov 01, 1999
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 01, 1999
27 yr ago
Today
Pharmaceutical detail
Active ingredient
ESTROPIPATE
Strength
0.75MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 040296
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ESTROPIPATE
- 1999ESTROPIPATEGeneric (ANDA)
ANDA 040359 · PHARMOBEDIENT
- 1996ESTROPIPATEGeneric (ANDA)
ANDA 040135 · BARR
- 1993ESTROPIPATEGeneric (ANDA)
ANDA 081213 · WATSON LABS
- 1993ESTROPIPATEGeneric (ANDA)
ANDA 081214 · WATSON LABS
- 1993ESTROPIPATEGeneric (ANDA)
ANDA 081216 · WATSON LABS
- 1993ESTROPIPATEGeneric (ANDA)
ANDA 081215 · WATSON LABS TEVA
- 1991ORTHO-ESTGeneric (ANDA)
ANDA 089582 · SUN PHARM INDS INC
- 1991ORTHO-ESTGeneric (ANDA)
ANDA 089567 · SUN PHARM INDS INC
- —OGENGeneric (ANDA)
ANDA 084710 · PHARMACIA AND UPJOHN
- —OGEN .625Generic (ANDA)
ANDA 083220 · PFIZER
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
